DaVita Inc. (NYSE:DVA) Shares Sold by Patton Fund Management Inc.

Patton Fund Management Inc. decreased its position in DaVita Inc. (NYSE:DVA) by 13.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,684 shares of the company’s stock after selling 4,188 shares during the quarter. Patton Fund Management Inc.’s holdings in DaVita were worth $4,140,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board acquired a new position in shares of DaVita in the second quarter valued at approximately $235,000. MBB Public Markets I LLC purchased a new position in DaVita in the 2nd quarter valued at approximately $582,000. The Manufacturers Life Insurance Company grew its stake in shares of DaVita by 0.3% in the second quarter. The Manufacturers Life Insurance Company now owns 45,244 shares of the company’s stock worth $6,269,000 after acquiring an additional 150 shares in the last quarter. Creative Planning increased its position in shares of DaVita by 5.0% during the second quarter. Creative Planning now owns 8,297 shares of the company’s stock worth $1,150,000 after acquiring an additional 394 shares during the period. Finally, B. Riley Wealth Advisors Inc. raised its stake in shares of DaVita by 78.9% in the second quarter. B. Riley Wealth Advisors Inc. now owns 4,130 shares of the company’s stock valued at $572,000 after acquiring an additional 1,822 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Stock Down 1.3 %

Shares of NYSE DVA opened at $173.17 on Wednesday. DaVita Inc. has a 1 year low of $105.82 and a 1 year high of $178.75. The company has a market capitalization of $14.20 billion, a price-to-earnings ratio of 18.68, a price-to-earnings-growth ratio of 0.82 and a beta of 0.92. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The business has a 50-day moving average of $159.01 and a two-hundred day moving average of $154.48.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period last year, the company earned $2.85 earnings per share. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. On average, analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on DVA. Truist Financial boosted their target price on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Barclays boosted their price objective on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.